MDT

100.19

-0.4%↓

A

147.66

-0.31%↓

VEEV

240.37

+1.66%↑

HQY

98.78

+1.46%↑

PHR.US

17.07

-0.7%↓

MDT

100.19

-0.4%↓

A

147.66

-0.31%↓

VEEV

240.37

+1.66%↑

HQY

98.78

+1.46%↑

PHR.US

17.07

-0.7%↓

MDT

100.19

-0.4%↓

A

147.66

-0.31%↓

VEEV

240.37

+1.66%↑

HQY

98.78

+1.46%↑

PHR.US

17.07

-0.7%↓

MDT

100.19

-0.4%↓

A

147.66

-0.31%↓

VEEV

240.37

+1.66%↑

HQY

98.78

+1.46%↑

PHR.US

17.07

-0.7%↓

MDT

100.19

-0.4%↓

A

147.66

-0.31%↓

VEEV

240.37

+1.66%↑

HQY

98.78

+1.46%↑

PHR.US

17.07

-0.7%↓

Search

Avalo Therapeutics

Open

16.94 2.05

Overview

Share price change

24h

Current

Min

16.46

Max

17.45

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+124.32% upside

Dividends

By Dow Jones

Next Earnings

19 Mar 2026

Avalo Therapeutics Chart

Past performance is not a reliable indicator of future results.

Related News

7 Jan 2026, 23:11 UTC

Earnings

Samsung Electronics Expects Record Fourth-Quarter Profit Beat

7 Jan 2026, 22:55 UTC

Major Market Movers

Defense Stocks Rebound After Trump Says He Wants $1.5 Trillion Military Budget in 2027

7 Jan 2026, 21:39 UTC

Major Market Movers

Raytheon Down Following Trump Post Criticizing Company

7 Jan 2026, 20:13 UTC

Major Market Movers

AbbVie, Revolution Medicines Stocks Gain on Report of Possible Acquisition

7 Jan 2026, 20:03 UTC

Major Market Movers

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Executive Pay

7 Jan 2026, 23:46 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

7 Jan 2026, 23:46 UTC

Market Talk

Nikkei May Decline as China-Japan Tensions Linger -- Market Talk

7 Jan 2026, 23:42 UTC

Acquisitions, Mergers, Takeovers

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 5th Update

7 Jan 2026, 23:34 UTC

Market Talk

Gold Edges Higher Amid Lingering Geopolitical Risks -- Market Talk

7 Jan 2026, 23:29 UTC

Acquisitions, Mergers, Takeovers

Constellation Closes Deal for Calpine, Creating Biggest Electricity Generator -- Barrons.com

7 Jan 2026, 22:48 UTC

Market Talk

Infratil's Discount to Net Asset Value Too Good to Ignore -- Market Talk

7 Jan 2026, 22:46 UTC

Earnings

Samsung Electronics Estimates 2025 Rev KRW332.770T Vs KRW300.870T >005930.SE

7 Jan 2026, 22:45 UTC

Earnings

Samsung Electronics Estimates 2025 Oper Pft KRW43.530T Vs KRW32.730T >005930.SE

7 Jan 2026, 22:43 UTC

Acquisitions, Mergers, Takeovers

Revolution Medicines Draws Takeover Interest -- 2nd Update

7 Jan 2026, 22:42 UTC

Earnings

Samsung Electronics 4Q Oper Pft Estimate Beat FactSet-Compiled Consensus Forecast

7 Jan 2026, 22:41 UTC

Earnings

Samsung Electronics Sees 4Q Oper Pft KRW20.000T Vs KRW6.490T >005930.SE

7 Jan 2026, 22:41 UTC

Earnings

Samsung Electronics Sees 4Q Rev KRW93.000T Vs KRW75.790T >005930.SE

7 Jan 2026, 22:40 UTC

Major Market Movers

Defense Stocks Rebound After Trump Says He Wants $1.5T Military Budget in 2027

7 Jan 2026, 22:31 UTC

Market Talk

Macro Tailwinds Strengthen for Chalice Mining -- Market Talk

7 Jan 2026, 22:22 UTC

Market Talk

Northern Star's Run of Disruptions Increasingly a Concern -- Market Talk

7 Jan 2026, 22:01 UTC

Market Talk

Valuations of New Zealand Property Stocks Supportive -- Market Talk

7 Jan 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

7 Jan 2026, 21:46 UTC

Market Talk

Northern Star's Revised Guidance Looks Achievable -- Market Talk

7 Jan 2026, 21:22 UTC

Acquisitions, Mergers, Takeovers

Eli Lilly to Buy Ventyx Biosciences for $14 a Share >LLY VTYX

7 Jan 2026, 21:18 UTC

Acquisitions, Mergers, Takeovers

Lilly To Acquire Ventyx Biosciences To Advance Oral Therapies Targeting Inflammatory-mediated Diseases >LLY VTYX

7 Jan 2026, 21:05 UTC

Acquisitions, Mergers, Takeovers

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 4th Update

7 Jan 2026, 20:29 UTC

Acquisitions, Mergers, Takeovers

AbbVie Near Deal for Revolution Medicines -- Update

7 Jan 2026, 20:27 UTC

Market Talk

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

7 Jan 2026, 19:58 UTC

Market Talk

Oil Falls As U.S. to Receive Sanctioned Venezuelan Crude -- Market Talk

7 Jan 2026, 19:48 UTC

Major Market Movers

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Exec Pay

Peer Comparison

Price change

Avalo Therapeutics Forecast

Price Target

By TipRanks

124.32% upside

12 Months Forecast

Average 38 USD  124.32%

High 48 USD

Low 25 USD

Based on 5 Wall Street analysts offering 12 month price targets forAvalo Therapeutics - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

5 ratings

5

Buy

0

Hold

0

Sell

Financials

$

help-icon Live chat